ALLA SOYFER: Open Payments
NPI 1679636344 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,962 in 114 payments from 23 companies in 2025. Trend: 2023 $2,581 · 2024 $2,256 · 2025 $2,962
Food & beverage: $2,962
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $422 |
| ABBVIE INC. | 24 | $257 |
| AstraZeneca Pharmaceuticals LP | 6 | $242 |
| GlaxoSmithKline, LLC. | 6 | $207 |
| Axsome Therapeutics, Inc. | 5 | $198 |
| Verona Pharma, Inc. | 5 | $183 |
| Alkermes, Inc. | 5 | $180 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $179 |
| Supernus Pharmaceuticals, Inc. | 3 | $152 |
| Lilly USA, LLC | 7 | $147 |
Products named: Ozempic, JARDIANCE, Auvelity, Ohtuvayre, Qelbree, Wegovy, Leqembi, AIRSUPRA.
Industry payments across IN — which companies pay providers there.
